← FDA DRUG APPROVALS

FDA NDA · NDA018370

FUROSEMIDE

Sponsor: SUPERPHARM

APPLICATION
NDA018370
TYPE
NDA
LATEST ACTION
1991-04-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

FUROSEMIDEDiscontinued
FUROSEMIDE 40MG · TABLET · ORAL
FUROSEMIDEDiscontinued
FUROSEMIDE 20MG · TABLET · ORAL

Approval history

1991-04-26Labeling · Supplement 34AP
1989-10-24Labeling · Supplement 30AP
1989-05-17Labeling · Supplement 29AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →